ASTEX THERAPEUTICS
DEAD

Serial Number

78684737

Owner

ASTEX THERAPEUTICS LIMITED

Attorney

Nancy C. DiConza

Filing Date

Aug 3, 2005

Add to watchlist:

No watchlists yet
View on USPTO

ASTEX THERAPEUTICS Trademark

Serial Number: 78684737

ASTEX THERAPEUTICS is a trademark filed by ASTEX THERAPEUTICS LIMITED on August 3, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ASTEX THERAPEUTICS LIMITED (14 trademarks)

436 CAMBRIDGE SCIENCE PARK, MILTON ROAD
CAMBRIDGE CB40QA , GB

Entity Type: 24

Trademark Details

Filing Date

August 3, 2005

Registration Date

Not Registered

Published for Opposition

July 12, 2011

Goods & Services

(Based on 44(e)) Computer software for the manipulation and presentation of data for use in relation to drug discovery, biotechnology research and scientific analysis

(Based on Intent to Use) Pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, neurological, dermatological, hematological, bone, respiratory, central nervous system, endrocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders, allergic reactions, metabolic disorders, ocular disorders, and for use in oncology; pharmaceuticals, namely, anti-inflammatory agents and anti-infectives; all of the foregoing not including cardiovascular pharmaceuticals or chemicals for cardiovascular medical purposes

(Based on 44(e)) Chemicals, chemical compounds and chemical preparations for non-medical purposes, namely, those for use in biotechnology; chemicals, chemical compounds and chemical preparations for medical research purposes, namely, those for use in drug discovery and the manufacture or development of pharmaceuticals, not including cardiovascular pharmaceuticals or chemicals for cardiovascular medical purposes; (Based on Intent to Use) diagnostic preparations and/or reagents for clinical or medical laboratory use, not including cardiovascular pharmaceuticals or chemicals for cardiovascular medical purposes

(Based on 44(e)) Drug discovery services in the nature of pharmaceutical research and pharmaceutical drug development; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development

Filing History

ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Nov 22, 2011 MAB5
ABANDONMENT - AFTER PUBLICATION
Nov 22, 2011 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Nov 15, 2011 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 10, 2011 ETOF
POST PUBLICATION AMENDMENT - ENTERED
Jul 29, 2011 CHPB
ASSIGNED TO PETITION STAFF
Jul 25, 2011 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 21, 2011 EPPA
PUBLISHED FOR OPPOSITION
Jul 12, 2011 PUBO
NOTICE OF PUBLICATION
Jun 22, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 6, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2011 TROA
NON-FINAL ACTION MAILED
Nov 15, 2010 CNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2010 CNRT
AMENDMENT FROM APPLICANT ENTERED
Oct 22, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2010 CRFA
PAPER RECEIVED
Oct 18, 2010 MAIL
INQUIRY AS TO SUSPENSION MAILED
Apr 19, 2010 CNSI
SUSPENSION INQUIRY WRITTEN
Apr 19, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 29, 2010 RCCK
LETTER OF SUSPENSION MAILED
Sep 28, 2009 CNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2009 CNSL
AMENDMENT FROM APPLICANT ENTERED
Sep 22, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2009 CRFA
PAPER RECEIVED
Sep 21, 2009 MAIL
INQUIRY AS TO SUSPENSION MAILED
Sep 4, 2009 CNSI
SUSPENSION INQUIRY WRITTEN
Sep 4, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 18, 2009 RCCK
LETTER OF SUSPENSION MAILED
Feb 18, 2009 CNSL
SUSPENSION LETTER WRITTEN
Feb 18, 2009 CNSL
AMENDMENT FROM APPLICANT ENTERED
Feb 18, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2009 CRFA
PAPER RECEIVED
Feb 17, 2009 MAIL
INQUIRY AS TO SUSPENSION MAILED
Feb 5, 2009 CNSI
SUSPENSION INQUIRY WRITTEN
Feb 5, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 17, 2009 RCCK
LETTER OF SUSPENSION MAILED
Jul 17, 2008 CNSL
SUSPENSION LETTER WRITTEN
Jul 17, 2008 CNSL
AMENDMENT FROM APPLICANT ENTERED
Jul 16, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2008 CRFA
PAPER RECEIVED
Jul 14, 2008 MAIL
INQUIRY AS TO SUSPENSION MAILED
Jul 3, 2008 CNSI
SUSPENSION INQUIRY WRITTEN
Jul 3, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 3, 2008 RCCK
LETTER OF SUSPENSION MAILED
Jan 3, 2008 CNSL
SUSPENSION LETTER WRITTEN
Jan 2, 2008 CNSL
AMENDMENT FROM APPLICANT ENTERED
Dec 20, 2007 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2007 CRFA
PAPER RECEIVED
Dec 13, 2007 MAIL
INQUIRY AS TO SUSPENSION MAILED
Nov 21, 2007 CNSI
SUSPENSION INQUIRY WRITTEN
Nov 20, 2007 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 27, 2007 RCCK
ASSIGNED TO LIE
Oct 27, 2007 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 26, 2007 RCSC
ASSIGNED TO LIE
Apr 26, 2007 ALIE
LETTER OF SUSPENSION MAILED
Oct 6, 2006 CNSL
SUSPENSION LETTER WRITTEN
Oct 6, 2006 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2006 TROA
AMENDMENT FROM APPLICANT ENTERED
Sep 11, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2006 CRFA
PAPER RECEIVED
Aug 31, 2006 MAIL
NON-FINAL ACTION MAILED
Feb 28, 2006 CNRT
NON-FINAL ACTION WRITTEN
Feb 27, 2006 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2006 DOCK
NEW APPLICATION ENTERED
Aug 9, 2005 NWAP